In addition, the treatment of the IL-6 receptor (IL-6R) blocking antibody tocilizumab prior to an open tibia fracture [25] reduced blood-brain barrier breakdown, enhanced hippocampus activation of microglia, and cognitive impairment. Here, IL6R is linked to Cognitive impairment.